CA2550573C - Cardiac monitoring - Google Patents

Cardiac monitoring Download PDF

Info

Publication number
CA2550573C
CA2550573C CA2550573A CA2550573A CA2550573C CA 2550573 C CA2550573 C CA 2550573C CA 2550573 A CA2550573 A CA 2550573A CA 2550573 A CA2550573 A CA 2550573A CA 2550573 C CA2550573 C CA 2550573C
Authority
CA
Canada
Prior art keywords
variability
atrial fibrillation
beat
processor
relevance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2550573A
Other languages
French (fr)
Other versions
CA2550573A1 (en
Inventor
Lev Korzinov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cardionet LLC
Original Assignee
Cardionet LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34750385&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2550573(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cardionet LLC filed Critical Cardionet LLC
Publication of CA2550573A1 publication Critical patent/CA2550573A1/en
Application granted granted Critical
Publication of CA2550573C publication Critical patent/CA2550573C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/024Detecting, measuring or recording pulse rate or heart rate
    • A61B5/02405Determining heart rate variability
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/318Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/346Analysis of electrocardiograms
    • A61B5/349Detecting specific parameters of the electrocardiograph cycle
    • A61B5/361Detecting fibrillation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/318Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/346Analysis of electrocardiograms
    • A61B5/349Detecting specific parameters of the electrocardiograph cycle
    • A61B5/363Detecting tachycardia or bradycardia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362Heart stimulators
    • A61N1/365Heart stimulators controlled by a physiological parameter, e.g. heart potential
    • A61N1/36592Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by the heart rate variability
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39Heart defibrillators
    • A61N1/395Heart defibrillators for treating atrial fibrillation

Abstract

Systems and techniques for monitoring cardiac activity. In one aspect, a method includes collecting information describing the variability in heart rate over a series of beats, designating variability at a lower end of physiological values as being largely irrelevant to atrial fibrillation, designating variability in a midrange of physiological values as being indicative of atrial fibrillation, designating variability in an upper range of physiological values as being negatively indicative of atrial fibrillation, and determining a relevance of the variability described in the collection to atrial fibrillation.

Description

CARDIAC MONITORING
BACKGROUND
The following description relates to cardiac monitoring, for example, by monitoring cardiac electrical activity.
The electrical activity of the heart can be monitored to track various aspects of the functioning of the heart. Given the volume conductivity of the body, electrodes on the body surface or beneath the skin often display potential differences related to this activity. Anomalous electrical activity can be indicative of disease states or other physiological conditions that can range from benign to deadly.
One example of such a physiological condition is atrial fibrillation. Atrial fibrillation involves the loss of synchrony between the atria and the ventricles. In complex atrial fibrillation, long-lived wavelets of depolarization travel along circular paths in the atria. This can lead to irregular ventricular beating as well as blood stagnation and clotting in the atria.
Atrial fibrillation is among the most common forms of cardiac arrhythmia and may affect more than two million people annually. Atrial fibrillation has been associated with stroke, congestive heart failure, and cardiomyopathy.
Another example of such a physiological condition is atrial flutter. Atrial flutter also involves the loss of synchrony between the atria and the ventricles. In atrial flutter, multiple atrial waveforms reach the atrioventricular (AV) node during each ventricular beat due to, e.g., atrial scars, an atrial infarction, or a re-entrant circuit encircling a portion of the right atrium.
Atrial flutter is less common than atrial fibrillation but is also associated with stroke, congestive heart failure, and cardiomyopathy.
SUMMARY
In accordance with one aspect of the invention, there is provided a method for producing an indication of relevance of variability in heart rate to atrial fibrillation. The method involves causing a processor to collect information describing the variability in heart rate over a series of beats, and causing the processor to determine factors reflecting the beat-to-beat variability in rate of successive heart beats. The factors are lowest when the beat-to-beat variability is lowest and the factors increase non-linearly when the beat-to-beat variability grows. The factors include a first factor. The method further involves: in response to the first factor reflecting beat-to-beat variability at a lower end of physiological values of a human heart, causing the processor to designate the variability reflected in the first factor as being substantially irrelevant to atrial fibrillation; in response to the first factor reflecting beat-to-beat variability in a midrange of physiological values of a human heart, causing the processor to designate the variability reflected in the first factor as being positively indicative of atrial fibrillation; in response to the first factor reflecting beat-to-beat variability in an upper range of physiological values of a human heart, causing the processor to designate the variability reflected in the first factor as being negatively indicative of atrial fibrillation; causing the processor to determine a relevance of the variability to atrial fibrillation; and causing the processor to produce a signal indicating said relevance of the variability in heart rate to atrial fibrillation.
Designating variability may involve multiplying the first factor by a weighting factor.
Collecting information may involve collecting information describing a variability in R to R intervals over a series of beats.
Collecting information describing the variability may involve collecting infounation that is a function of a ratio of a first R to R interval and an immediately preceding R to R interval.
The factors may be factors DRR(n) as given by n ¨1) DRR(n)= ABS RR(n, V.
RI?(n,n ¨ 1)+ RR(n ¨1,n ¨ 2) /2 Designating variability at the lower end of physiological values as being largely irrelevant may involve designating information related to factors DRR(n) less than about 0.02 as being largely irrelevant.
Designating variability at the midrange of physiological values as being indicative of atrial fibrillation may involve designating information related to factors DRR(n) greater than about 0.02 and less than about 0.15 as being indicative of atrial fibrillation.
Designating variability at the upper range of physiological values as being negatively indicative of atrial fibrillation may involve designating information related to factors DRR(n) greater than about 0.15 as being negatively indicative of atrial fibrillation.
Collecting information describing the variability may involve collecting the variability in heart rate over a series of between 20 and 200 of the recent R to R intervals.
Determining the relevance of the variability may involve determining the relevance of the variability to sustained atrial fibrillation.
The series of R to R intervals may be a continuous series of R to R intervals.
Causing the processor to determine the relevance of the variability to atrial fibrillation may involve causing the processor to determine the relevance of the variability to atrial fibrillation using non-linear statistics.
The method may further involve causing the processor to identify an atrial fibrillation event based on the determined relevance.
The method may further involve causing the processor to identify an end of the atrial fibrillation event based on the determined relevance.
The method may further involve causing the processor to transition into an event state associated with atrial fibrillation in response to identification of the atrial fibrillation event.
The method may further involve causing the processor to transmit an indication of the atrial fibrillation event to a remote receiver from an ambulatory patient.
Determining the relevance of the variability to atrial fibrillation may involve receiving information identifying a ventricular beat, and may also involve assigning a preset value indicating that the variability is negatively indicative of atrial fibrillation.
The method may further involve causing the processor to identify a ventricular tachycardia event based at least in part on the information identifying the ventricular beat.
In accordance with another aspect of the invention, there is provided at least one computer-readable medium comprising codes stored thereon for directing a processor to: collect information describing the variability in heart rate over a series of beats;
determine factors reflecting the beat-to-beat variability in rate of successive heart beats, wherein the factors are lowest when the beat-to-beat variability is lowest and the factors increase non-linearly when the beat-to-beat variability grows, and wherein the factors comprise a first factor; in response to the first factor reflecting beat-to-beat variability at a lower end of physiological values of a human heart, designate the variability reflected in the first factor as being substantially irrelevant to atrial fibrillation; in response to the first factor reflecting beat-to-beat variability in a midrange of physiological values of a human heart, designate the variability reflected in the first factor as being positively indicative of atrial fibrillation; in response to the first factor reflecting beat-to-beat variability in an upper range of physiological values of a human heart, designate the variability reflected in the first factor as being negatively indicative of atrial fibrillation;
determine a relevance of the variability to atrial fibrillation; and produce a signal indicating said relevance of the variability in heart rate to atrial fibrillation.
The codes for directing the processor to designate variability may include codes for directing the processor to multiply the first factor by a weighting factor.
The codes for directing the processor to collect information may include codes for directing the processor to collect information describing a variability in R
to R intervals over a series of beats.
The codes for directing the processor to collect information describing the variability may include codes for directing the processor to collect information that is a function of a ratio of a first R to R interval and an immediately preceding R to R interval.
The factors may be factors DRR(n) as given by DRR(n)= ABS RR(n,n ¨1) V
R1?(n,n ¨1)+ RR(n ¨1,n ¨ 2) / 2 The codes for directing the processor to designate variability at the lower end of physiological values as being largely irrelevant may include codes for directing the processor to designate information related to factors DRR(n) less than about 0.02 as being largely irrelevant.
The codes for directing the processor to designate variability at the midrange of physiological values as being indicative of atrial fibrillation may include codes for directing the processor to designate information related to factors DRR(n) greater than about 0.02 and less than about 0.15 as being indicative of atrial fibrillation.
The codes for directing the processor to designate variability at the upper range of physiological values as being negatively indicative of atrial fibrillation may include codes for directing the processor to designate information related to factors DRR(n) greater than about 0.15 as being negatively indicative of atrial fibrillation.
The codes for directing the processor to collect information describing the variability may include codes for directing the processor to collect the variability in heart rate over a series of between 20 and 200 of the recent R to R intervals.
The codes for directing the processor to determine the relevance of the variability may include codes for directing the processor to determine the relevance of the variability to sustained atrial fibrillation.
The series of R to R intervals may be a continuous series of R to R intervals.
The codes for directing the processor to determine the relevance of the variability to atrial fibrillation may include codes for directing the processor to determine the relevance of the variability to atrial fibrillation using non-linear statistics.
The at least one computer-readable medium may further include codes stored thereon for directing the processor to identify an atrial fibrillation event based on the determined relevance.
The at least one computer-readable medium may further include codes stored thereon for directing the processor to identify an end of the atrial fibrillation event based on the determined relevance.
The at least one computer-readable medium may further include codes stored thereon for directing the processor to transition into an event state associated with atrial fibrillation in response to identification of the atrial fibrillation event.
The at least one computer-readable medium may further include codes stored thereon for directing the processor to cause an indication of the atrial fibrillation event to be transmitted to a remote receiver from an ambulatory patient.
The codes for directing the processor to determine the relevance of the variability to atrial fibrillation may include codes for directing the processor to receive information identifying a ventricular beat, and may also include codes for directing the processor to assign a preset value indicating that the variability is negatively indicative of atrial fibrillation.
The at least one computer-readable medium may further include codes stored thereon for directing the processor to identify a ventricular tachycardia event based at least in part on the information identifying the ventricular beat.
In accordance with another aspect of the invention, there is provided an apparatus for producing an indication of relevance of variability in heart rate to atrial fibrillation. The apparatus includes the at least one computer-readable medium described above, and the processor.
4a In accordance with another aspect of the invention, there is provided an apparatus for producing an indication of relevance of variability in heart rate to atrial fibrillation. The apparatus includes a means for collecting information describing the variability in heart rate over a series of beats, and a means for determining factors reflecting the beat-to-beat variability in rate of successive heart beats. The factors are lowest when the beat-to-beat variability is lowest and the factors increase non-linearly when the beat-to-beat variability grows. The factors include a first factor. The apparatus further includes: a means for designating the variability reflected in the first factor as being substantially irrelevant to atrial fibrillation if the first factor reflects beat-to-beat variability at a lower end of physiological values of a human heart, for designating the variability reflected in the first factor as being positively indicative of atrial fibrillation if the first factor reflects beat-to-beat variability in a midrange of physiological values of a human heart, and for designating the variability reflected in the first factor as being negatively indicative of atrial fibrillation if the first factor reflects beat-to-beat variability in an upper range of physiological values of a human heart; a means for determining a relevance of the variability to atrial fibrillation; and a means for producing a signal indicating said relevance of the variability in heart rate to atrial fibrillation.
The means for designating variability may include a means for multiplying the first factor by a weighting factor.
The means for collecting information may be configured to collect information describing a variability in R to R intervals over a series of beats.
The means for collecting information may be configured to collect information that is a function of a ratio of a first R to R interval and an immediately preceding R
to R interval.
The factors may be factors DRR(n) as given by ( n ¨
DRR(n) = ABS RR(n, 1) ¨1)+ RR(n ¨1,n ¨ 2) 2 The means for designating variability may be configured to designate variability at the lower end of physiological values as being largely irrelevant if information related to factors DRR(n) is less than about 0.02.
4b The means for designating variability may be configured to designate variability at the midrange of physiological values as being indicative of atrial fibrillation if information related to factors DRR(n) is greater than about 0.02 and less than about 0.15.
The means for designating variability may be configured to designate variability at the upper range of physiological values as being negatively indicative of atrial fibrillation if information related to factors DRR(n) is greater than about 0.15.
The means for collecting information may include a means for collecting the variability in heart rate over a series of between 20 and 200 of the recent R to R
intervals.
The means for determining the relevance of the variability may include a means for determining the relevance of the variability to sustained atrial fibrillation.
The series of R to R intervals may be a continuous series of R to R intervals.
The means for determining the relevance of the variability to atrial fibrillation may be configured to determine the relevance of the variability to atrial fibrillation using non-linear statistics.
The apparatus may further include a means for identifying an atrial fibrillation event based on the determined relevance.
The apparatus may further include a means for identifying an end of the atrial fibrillation event based on the determined relevance.
The apparatus may further include a means for transitioning into an event state associated with atrial fibrillation in response to identification of the atrial fibrillation event.
The apparatus may further include a means for transmitting an indication of the atrial fibrillation event to a remote receiver from an ambulatory patient.
The means for determining the relevance of the variability to atrial fibrillation may include a means for receiving information identifying a ventricular beat, and may also include a means for assigning a preset value indicating that the variability is negatively indicative of atrial The apparatus may further include a means for identifying a ventricular tachycardia event based at least in part on the information identifying the ventricular beat.
The cardiac monitoring systems and techniques may provide one or more of the following advantages. Atrial fibrillation ("AFib") and/or atrial flutter ("AFlut," with "AF"
4c referring to either) can be distinguished from other types of cardiac arrhythmia, such as the normal sinus rhythm irregularity, irregularity from various types of heart blocks, and the irregularity associated with premature ventricular contractions. The described systems and techniques may be a practical approach to calculating the beat-to-beat irregularity and may provide improved positive predictability of AF. Moreover, the described systems and techniques may be able to identify sustained AF episodes, where AF continues for more that approximately 20 beats and has an increased clinical significance.
For example, when systems and techniques according to some embodiments described here were used to analyze the MIT-BIH arrhythmia database, available from MIT-BIH Database Distribution, MIT Room E25-505A, Cambridge, MA 02139, USA, a sensitivity to AF
in excess of 90% and a positive predictivity in excess of 96% were obtained.
The described systems and techniques may be well-adapted to monitoring cardiac signals of ambulatory patients who are away from controlled environments such as hospital beds or treatment facilities. The cardiac signals obtained from to ambulatory patients may be noisier and otherwise strongly impacted by the patients' heightened levels of activity.
Thus, improved monitoring systems and techniques, such as those described herein, are required for ambulatory patients.
The described systems and techniques may also be well-adapted to real-time monitoring of arrhythmia patients, where minimal delays in distinguishing between different types of cardiac arrhythmia can speed the delivery of any urgent medical care. The described systems and techniques also require minimal computational resources. Further, the described systems and techniques do not require training before different types of cardiac arrhythmia can be distinguished.
The details of one or more implementations of the invention are set forth in the accompa-flying drawings and the description below. Other features and advantages will be apparent from the description and drawings, and from the claims.
4d DESCRIPTION OF DRAWINGS
FIG. 1 shows a system in which a cardiac signal is monitored for medical purposes.
FIG. 2 shows an example of a cardiac signal.
FIG. 3 shows an example of instrumentation for cardiac monitoring using a cardiac signal.
FIG 4 shows an example state diagram of a cardiac monitoring system during cardiac monitoring.
FIG. 5 shows a process for cardiac monitoring for the detection of an AF
event.
FIG 6A shows a process for determining the variability in the recent R to R
intervals and identifying if the variability is relevant to either the onset or termination of AF.
FIG. 6B shows a graph of factor DRR(n) as a function of RR(n-1,n-2)/RR(n,n-1).
FIG 7 shows a transformation function for weighting the variability in the timing of recent beats.
FIG 8 shows an example of instrumentation for cardiac monitoring using an electrocardiogram trace.
FIG. 9 shows an example state diagram of a cardiac monitoring system that accommodates the variability caused by ventricular beats.
4e FIG. 10 shows a process for determining the variability of recent R to R
intervals and identifying if the variability is relevant to the onset of AF while accommodating the variability caused by ventricular beats.
FIG 11 shows a process for determining the variability in recent R to R
intervals and identifying if the variability is relevant to the termination of AF while accommodating the variability caused by ventricular beats.
Like reference symbols in the various drawings indicate like elements.
DETAILED DESCRIPTION
FIG 1 shows a system 100 in which a cardiac signal is monitored for medical purposes. System 100 includes an individual 105, instrumentation 110, a signal path 115, and a receiver 120. Individual 105 can be a patient or a healthy individual for whom monitoring of one or more biological signals is deemed to be appropriate. Instrumentation 110 can include one or more sensing, calibration, signal processing, control, data storage, and transmission elements suitable for generating and processing the cardiac signal, as well as relaying all or a portion of the cardiac signal over path 115. Path 115 can be any suitable medium for data transmission, including wired and wireless media suitable for carrying optical and/or electrical signals. The receiver 120 can include a receiver element for receiving the transmitted signal, as well as various data processing and storage elements for extracting and storing the information carried by the transmission regarding the state of individual 105. The receiver 120 can be a medical system in that receiver 120 presents information to medical personnel or to a medical expert system for analysis.
The receiver 120 either can reside remotely from instrumentation 110 in that receiver 120 is not located at the same site as instrumentation 110 (e.g., at the same hospital, nursing home, or other medical care facility) or the receiver 120 can reside within the same general area or vicinity as instrumentation 110 (e.g., within the same room, building, or health care facility).
FIG 2 shows an example of a cardiac signal, namely the trace of a scalar electrocardiogram 200. Electrocardiogram trace 200 follows a potential difference 205 measured between two points on the body surface of an individual. Potential difference 205 changes with time 210 in a manner characteristic of the physiology and function of an individual's heart.
Electrocardiogram trace 200 generally includes features characteristic with particular aspects of cardiac activity. For example, trace 200 includes a series of QRS
complexes 215, 220, 225 associated with activation of the ventricles. QRS complex 225 includes an R-wave Rõ, QRS complex 220 includes an R-wave Rn.1, and QRS complex 215 includes an R-wave Rn.2. The time between successive R-waves can be referred to as the R to R
interval. In particular, the R to R interval between R-wave Rn and R-wave Rn.1 is RR(n,n-1) and the R to R interval between R-wave Rn.1 and R-wave Rn_2 is RR(n-1,n-2).
FIG 3 shows an example of instrumentation 110 for cardiac monitoring using a cardiac signal such as electrocardiogram trace 200. Instrumentation 110 includes a sensor 305, a signal amplifier/processor 310, a beat detector 315, an atrial fibrillation/atrial flutter (AF) detector 320, decision logic 325, and an event generator 330. Sensor 305 can include two or more electrodes subject to one or more potential differences that yield a voltage signal such as electrocardiogram trace 200. The electrodes can be body surface electrodes such as silver/silver chloride electrodes and can be positioned at defined locations to aid in monitoring the electrical activity of the heart. Sensor 305 can also include leads or other conductors that form a signal path to signal amplifier/processor 310. Signal amplifier/processor 310 can receive, amplify, and/or process the voltage signals. The processing can include filtering and digitization. The amplification and remainder of the processing can occur before or after digitization. Signal amplifier/processor 310 can provide the amplified and/or processed signal to beat detector 315.
Beat detector 315 is a device such as a circuit or other arrangement that identifies the time period between ventricular contractions. For example, beat detector 315 can be a QRS
detector in that it identifies successive QRS complexes (or an equivalent indicator of ventricular activity) and determines the beat-to-beat timing from the time between complexes. The beat-to-beat timing can be determined by measuring times between successive R-waves, such as RR(n,n-1) and RR(n-1,n-2) in electrocardiogram trace 200 (FIG
2). Beat detector 315 can provide information regarding the time period between ventricular contractions to AF detector 320.
AF detector 320 is a data processing device that analyzes information regarding the time period between ventricular contractions to detect AF. The detection of AF
can include distinguishing AF from other sources of ventricular irregularity, such as premature ventricular contraction, heart blocks, and normal sinus rhythm irregularity. The detection of AF can also include distinguishing between short AF episodes and sustained AF episodes.
Short AF
episodes generally include between two and 20 beats and may or may not have clinical significant, whereas sustained AF episodes generally include more than 20 beats and may have relatively greater clinical significance. The detection of AF can also include the detection of other types of irregularity caused by random refractory periods of the ventricles.
AF detector 320 can analyze information regarding the time period between ventricular contractions to detect AF using non-linear statistical approaches.
Non-linear statistics treats the relationship between variables as something other than a linear function.
Detail regarding an example non-linear statistical approach to detecting AF is given below.
AF detector 320 can provide information regarding the detection of AF to decision logic 325 Decision logic 325 is a set of instructions for determining when the AF
detected by AF detector 320 has commenced and terminated. For example, decision logic 325 can be embodied in a circuit or decision logic 325 can be executed by a data processing device such as AF detector 320. Decision logic 325 can also trigger the generation of an AF event by event generator 230.
Event generator 330 is a device such as a data processing device that prepares an AF
event for handling. An AF event is a period in time when the information content of the signal sensed by sensor 305 is deemed to be of increased relevance to the monitoring of AF.
AF events need not be of equal or predetermined duration. For example, an event associated with an sustained AF episode may have a longer duration than an event associated with a short AF episode.
Event generator 330 can prepare an AF event for handling by collecting information that summarizes the relevance of the event to the detection and/or monitoring of AF. For example, event generator 330 can excise data associated with the period identified as AF
from the amplified and processed signal output from signal amplifier/processor 310. Event generator 330 can also redact such data (e.g., by selecting the first three minutes worth when generating the event). Handling the AF event can include transmitting the AF
event over data link 115 or storing the AF event in a data storage device.
FIG 4 shows an example state diagram 400 of a cardiac monitoring system during cardiac monitoring. For example, state diagram 400 can relate to the operation of an assembly such as AF detector 320 and decision logic 325 in instrumentation 110 (FIG 3).
State diagram 400 includes an idle state 405 and an AF event state 410. Idle state 405 originates a reflexive transition 415 and a state transition 420. AF event state 410 originates a reflexive transition 425 and a state transition 430. Reflexive transition 415 is associated with a series of variability measurements. State transition 420 is triggered by the onset of AF-type variability as detected by such measurements. Reflexive transition 425 is associated with another series of variability measurements. State transition 430 is triggered by the end of AF-type variability as detected by such measurements.

In operation, a cardiac monitoring system can start in idle state 405 and measure the variability of a cardiac signal. For example, the system can measure the variability in the beat-to-beat timing of successive R-waves, such as the variability between RR(n,n-1) and RR(n-1,n-2) in electrocardiogram trace 200 (FIG 2). Once the variability has been identified as AF-type variability, the system transitions to AF event state 410 where the system continues to measure the variability of the cardiac signal. In AF event state 410, once the AF-type variability has ended, the system returns to idle state 405.
FIG 5 shows a process 500 for cardiac monitoring, e.g., for the detection of an AF
event. Process 500 can be performed by one or more data processing devices that perform data processing activities. The activities of process 500 can be performed in accordance with the logic of a set of machine-readable instructions, a hardware assembly, or a combination of these and/or other instructions. The activities in process 500 can be performed at any of a number of different elements in a system in which a biological signal is monitored. For example, in instrumentation 110 (FIG 3), the activities in process 900 can be performed at AF
detector 320, decision logic 325, and event generator 330.
The device performing process 500 receives information regarding the timing of recent beats at 505. The timing information can be received in discrete amounts (e.g., on a beat-to-beat basis) or in a collection that includes such information. Using the received timing information, the system determines the variability in the recent R to R
intervals at 510.
The variability in the R to R intervals can reflect the beat-to-beat change in heart rate over a set period or over a set number of beats.
The system can also identify the relevance of such variability to AF at 515.
The variability is relevant to AF when it is associated with a high probability that an individual undergoes AF at or near the time of the recent beats. Relevance can be identified by comparing the variability to a predetermined amount of variability or to an amount identified as typical for the monitored patient.
The system can also determine if the identified relevance of the variability is indicative of the monitored individual undergoing AF at decision 520. If not, the system returns to 505. This return can correspond to the system remaining in idle state 405 along reflexive transition 415 in state diagram 400 (FIG 4). If the system determines that the results of the monitoring are indicative of the individual undergoing AF, the system initiates an AF event at 525. This initiation of the AF event can correspond to the system transitioning to AF event state 410 in state diagram 400 (FIG 4). The initiation of such an event can include various activities that lead to the generation of an event, such as triggering an event generator to add markers to a data stream such as electrocardiogram trace 200 or excising a relevant portion of the data stream.
The system can continue to receive information regarding the timing of recent beats at 530. Using the received timing information, the system determines the variability in the recent R to R intervals at 535. The system can also identify the relevance of such variability to the end of AF at 540. The variability is relevant to the end of AF when it is associated with an increased probability that AF has halted. Relevance can be identified by comparing the variability to a predetermined amount of variability or to an amount identified as typical for the monitored patient.
The system can also determine if the identified relevance of the variability indicates that AF has ended in the monitored individual at decision 545. If not, the system returns to 530. This return can correspond to the system remaining in AF event state 410 along reflexive transition 425 in state diagram 400 (FIG 4). If the system determines that AF has ended in the monitored individual, the system returns to 555. This return can correspond to the system transitioning to idle state 405 in state diagram 400 (FIG 4).
FIG 6A shows a process 600 for determining the variability in the recent R to R
intervals and identifying if the variability is relevant to either the onset or termination of AF.
Process 600 can be performed independently or process 600 can be performed as part of a larger collection of activities. For example, process 600 can be performed as part of process 500, namely as steps 510, 515 or as steps 535, 540 (FIG 5). Various activities in process 600 can also be performed to trigger state transitions 420, 430 in state diagram 400 (FIG 4).
The system performing process 600 can compare the most recent R to R interval (e.g., RR(n,n-1) of FIG 2) with the immediately preceding R to R interval (e.g., RR(n-1,n-2) of FIG 2) at 605. Such a comparison can yield a factor that reflects the beat-to-beat variability in heart rate. For example, a factor DRR(n), given by the expression RR(n,n ¨1) DRR(n)= ABS( 1/) Equation 1 RR(In,n ¨0+ RR(n ¨1,n ¨ 2) /2) can reflect the beat-to-beat variability in R to R interval and in heart rate.
A graph of factor DRR(n) as a function of RR(n-1,n-2)/RR(n,n-1) is shown in FIG 6B.
The system performing process 600 can also weight the comparison of the most recent R to R interval with the immediately preceding R to R interval according to the likelihood that the results of the comparison are indicative of AT at 610. The weighting can determine a role that the comparison will play in subsequent processing cardiac monitoring activities. For example, the weighting can include the whole or partial exclusion of a certain comparisons from subsequent cardiac monitoring activities.
One technique for weighting the comparison is through the use of a transformation, such as transformation function 700 shown in FIG 7. Transformation function 700 provides weights that are multiplied by the value of a comparison (e.g., factor DRR(n)) to reflect the relevance of the comparison to AF. The weights provided in transformation function 700 can be multiplied by the value of every comparison or by a selected subset of the comparisons.
One technique for selecting such a subset is discussed further below.
Transformation function 700 is adapted to the factor DRR(n) given in equation 1. In particular, transformation function 700 is adapted to overweight factor DRR(n) when factor DRR(n) is in a midrange of potential physiological values (e.g., when DRR(n) is greater than about 0.02 and less than about 0.15). Transformation function 700 is adapted to weight factor DRR(n) as being negatively indicative of AF when factor DRR(n) is at the upper range of potential physiological values (e.g., when DRR(n) is greater than about 0.157).
Transformation function 700 is adapted to weight factor DRR(n) as being largely irrelevant to AF when factor DRR(n) is at the lower range of potential physiological values (e.g., when DRR(n) is less than about 0Ø2). Transformation function 700 includes a scalar weight 705 that varies as a function of the comparison factor DRR(n) 710. In particular, weight 705 varies linearly between points 715, 720, 725, 730, 735. The values of points 715, 720, 725, 730, 735 are given in Table 1.
Point Comparison Weight DRR(n) 720 0.0206 0.0417 725 0.0642 0.9178 730 0.1427 0.1005 735 0.2 -0.3 Table 1 In operation, weight 705 for any value of the factor DRR(n) can be determined by linear interpolation between the weights of points 715, 720, 725, 730, 735.
The interpolation can be performed for each value of the factor DRR(n) as it arises or the results of a certain number of such interpolations can be stored in a look up table. For any value of the factor DRR(n) above 0.2, a weight of -0.3 can be assigned.

Returning to FIG 6A, the system performing process 600 can also add a weighted comparison to a collection of weighted comparisons for recent beats at 615.
For example, the system can form a FIFO stack or an array of weighted comparisons having a separate data element for each of between 10 and 200 (e.g., 100) of the most recent beats.
The system can also determine the relevance of the collection of weighted comparisons for recent beats to AF
at 620. The collection of weighted comparisons can be relevant to either the onset or termination of AF.
To determine the relevance, the system can sum the weighted comparisons to arrive at a number that represents the average relevance of the weighted comparisons in the collection.
The system can calculate such sums for several beats in a row before determining that the beat-to-beat variability is indicative of the onset or termination of AF. In one implementation, the system calculates the average of the weighted comparisons of the beats in the collection and compares this average with a first predetermined threshold to determine if the variability is indicative of the onset of AF and with a second predetermined threshold to determine if the variability is indicative of the termination of AF. In general, the first, onset threshold may be higher than the second, termination threshold. The difference between the onset and termination thresholds can introduce hysteresis into the state transitions to stabilize any system performing process 600.
FIG 8 shows an example of instrumentation for cardiac monitoring using an electrocardiogram trace, namely instrumentation 800. In addition to sensor 305, signal amplifier/processor 310, AF (AF) detector 320, decision logic 325, and event generator 330, instrumentation 800 also includes a QRS detector 805 and a ventricular beat detector 810.
QRS detector 805 and ventricular beat detector 810 can both receive an amplified and processed signal from signal amplifier/processor 310. QRS detector 805 is a device such as a circuit or other arrangement that identifies the time period between successive QRS
complexes. QRS detector 805 can provide information regarding the time period between successive QRS complexes to AF detector 320 Ventricular beat detector 810 is a device such as a circuit or other arrangement that identifies ventricular beats. Ventricular beats (i.e., premature ventricular beats) are irregular beats that interrupt the normal heart rhythm. Ventricular beats generally arise from a ventricular focus with enhanced automaticity. Ventricular beats may also result from reentry within the His-Purkinje system. The occurrence of ventricular beats is generally unrelated to AF. For example, the occurrence of ventricular beats can be used to identify ventricular tachycardia (e.g., when there are three or more consecutive ventricular beats). Ventricular beats may be precipitated by factors such as alcohol, tobacco, caffeine, and stress.
Ventricular beat detector 810 can monitor an electrocardiogram trace to identify ventricular beats. Various systems and techniques for identifying ventricular beats can be used. For example, the Mortara VERITAS Analysis Algorithm, available from Mortara Instrument, Inc.
(Milwaukee, WI), can be used. Ventricular beat detector 810 can also provide information regarding the occurrence of ventricular beats to AF detector 320.
Ventricular beat detector 810 can be housed together with QRS detector 805. An example of such a joint device is the ELI 250TM Electrocardiograph available from Mortara Instrument, Inc. (Milwaukee, WI).
Approaches for determining the variability in recent R to R intervals and identifying if the variability is relevant to either the onset or termination of AF can accommodate the variability caused by ventricular beats. FIG 9 shows an example state diagram 900 of a cardiac monitoring system that accommodates the variability caused by ventricular beats. In addition to idle state 405 and AF event state 410, state diagram 900 also includes a ventricular tachycardia (V-TACH) event state 905. Ventricular tachycardia is a rapid succession of ventricular contractions (e.g., between 140 and 220 per minute) generally caused by an abnormal focus of electrical activity in a ventricle. Ventricular tachycardia can last from a few seconds to several days and can be caused by serious heart conditions such as a myocardial infarction. AF event state 410 originates a state transition 910 that is triggered by the occurrence of three consecutive ventricular beats. V-TACH event state 905 originates a state transition 910 that is triggered by the end of a V-TACH event. The end of a V-TACH
event can be identified, e.g., when the rate of ventricular contractions falls below a predetermined value (e.g., a value between 100 and 200 bpm).
FIG 10 shows a process for determining the variability in recent R to R
intervals and identifying if the variability is relevant to the onset of AF while accommodating the variability caused by ventricular beats, namely a process 1000. Process 900 can be performed independently or process 1000 can be performed as part of a larger collection of activities. For example, process 1000 can be performed as part of process 500, namely as steps 510, 515 (FIG 5). Various activities in process 1000 can also be performed to trigger state transition 420 in state diagram 900 (FIG 9).
The system performing process 1000 can compare the recent R to R intervals with the respective, immediately-preceding R to R intervals at 1005 using, e.g., the expression in Equation 1 to reflect the beat-to-beat variability in heart rate. The system performing can also receive an indicator of the occurrence of a ventricular beat at 1010.
Such an indicator can be received, e.g., from a ventricular beat detector.
The system can create an array or other data structure that includes both the ventricular beat indicators and the R to R interval comparisons at 1015. The array can include the ventricular beat indicators and the R to R interval comparisons for between 10 and 200 (e.g., 100) of the most recent beats. The system can also weight the comparisons according to the likelihood that the R to R interval comparisons are relevant to AF at 1020 using, e.g., transformation function 700 (FIG 7).
The system can also assign a preset value to the R to R interval comparisons associated with ventricular beats at 1025. The preset value can be a penalty value in that the preset value reflects a decreased likelihood that the variability is indicative of an AF event.
The preset value can be selected in light of the approaches used to compare the R to R
intervals and to weight such comparisons. For example, when the R to R
intervals are compared using Equation 1 and the resulting comparisons are weighted using transformation function 700 (FIG 7), R to R interval comparisons associated with ventricular beats can be assigned a preset value of ¨0.06 and R to R intervals comparisons associated with the R to R
intervals immediately succeeding ventricular beats can be assigned a preset value of zero.
Using both the weighted and preset timing comparisons, the system can calculate the average value of an entry in the array of the most recent beats at 1030. If the system determines that the average is greater than 0.22 for the last five beats at decision 1035, then the system triggers the start of an AF event in the recent beats at 1040. On the other hand, if the system determines that the average is less than or equal to 0.22 for the last five beats, then the system returns to compare the recent R to R intervals with the previous R
to R interval at 1005.
FIG 11 shows a process for determining the variability in the recent R to R
intervals and identifying if the variability is relevant to the termination of AF while accommodating the variability caused by ventricular beats, namely a process 1100. Process 1100 can be performed independently or process 1100 can be performed as part of a larger collection of activities. For example, process 1100 can be performed as part of process 500, namely as steps 535, 540 (FIG. 5). Various activities in process 1100 can also be performed to trigger state transitions 430, 910, 915 in state diagram 900 (FIG 9).
The system performing process 1100 can perform the activities at 1005, 1010, 1015, 1020, 1025, 1030 as in process 1000. The system can also determine if the last three beats have been ventricular beats at decision 1105. For example, the system can determine if the last three beats are marked with a ventricular beat occurrence indicator such as that received at 1010.
If the system determines that the last three beats have been ventricular beats, the system triggers the end of the AF event at 1110 and, when appropriate, terminates a ventricular tachycardia event at 1115. The start and termination of the ventricular tachycardia event can transition the state of a system into and out of a V-TACH event, much like transitions 910, 915 in state diagram 900 (FIG. 9).
When the V-TACH event has been terminated at 1115 or when the system determines that the last three beats have not been ventricular beats at 115, the system then determines if the average of both the weighted and preset timing comparisons in the array of the most recent beats has dropped below 0.08 at decision 1120. If the average has not dropped below 0.08, the system returns to compare the recent R to R intervals with the previous R to R
interval at 1005. On the other hand, when the average has dropped below 0.08, the system triggers the end of the AF event at 1125. This triggering can transition the state of a system out of an AF event, much like transition 430 in state diagram 900 (FIG. 9).
Various implementations of the systems and techniques described here can be realized in digital electronic circuitry, integrated circuitry, specially designed ASICs (application specific integrated circuits), computer hardware, firmware, software, and/or combinations thereof. These various implementations can include one or more computer programs that are executable and/or interpretable on a programmable system including at least one programmable processor, which may be special or general purpose, coupled to receive data and instructions from, and to transmit data and instructions to, a storage system, at least one input device, and at least one output device.
These computer programs (also known as programs, software, software applications or code) may include machine instructions for a programmable processor, and can be implemented in a high-level procedural and/or object-oriented programming language, and/or in assembly/machine language. As used herein, the term "machine-readable medium" refers to any computer program product, apparatus and/or device (e.g., magnetic discs, optical disks, memory, Programmable Logic Devices (PLDs)) used to provide machine instructions and/or data to a programmable processor, including a machine-readable medium that receives machine instructions as a machine-readable signal. The term "machine-readable signal"
refers to any signal used to provide machine instructions and/or data to a programmable processor.

To provide for interaction with a user, the systems and techniques described here can be implemented on a computer having a display device (e.g., a CRT (cathode ray tube) or LCD (liquid crystal display) monitor) for displaying information to the user and a keyboard and a pointing device (e.g., a mouse or a trackball) by which the user can provide input to the computer. Other kinds of devices can be used to provide for interaction with a user as well;
for example, feedback provided to the user can be any form of sensory feedback (e.g., visual feedback, auditory feedback, or tactile feedback); and input from the user can be received in any form, including acoustic, speech, or tactile input.
The systems and techniques described here can be implemented in a computing environment that includes a back-end component (e.g., as a data server), or that includes a middleware component (e.g., an application server), or that includes a front-end component (e.g., a client computer having a graphical user interface or a Web browser through which a user can interact with an implementation of the systems and techniques described here), or any combination of such back-end, middleware, or front-end components. The components of the environment can be interconnected by any form or medium of digital data communication (e.g., a communication network). Examples of communication networks include a local area network ("LAN"), a wide area network ("WAN"), and the Internet.
The computing environment can include clients and servers. A client and server are generally remote from each other and typically interact through a communication network.
The relationship of client and server arises by virtue of computer programs running on the respective computers and having a client-server relationship to each other.
A number of implementations have been described. Nevertheless, it will be understood that various modifications may be made. Cardiac signals other than scalar electrocardiograms such as heart sounds can be monitored. Other weighting approaches and transformation functions can be used, depending upon the manner in which the timing of beats is compared. Weight 705 can be interpolated in any of a number of different ways such as a cubic spline between points 715, 720, 725, 730, 735. Cardiac monitoring can be performed in real time or delayed. The values of different parameters can be changed and useful results still obtained. For example, in FIG 7, point 735 can be repositioned to a comparison factor DRR(n) value above 0.2. Accordingly, other implementations are within the scope of the following claims.

Claims (55)

1. A
method for producing an indication of relevance of variability in heart rate to atrial fibrillation, the method comprising:
causing a processor to collect information describing the variability in heart rate over a series of beats;
causing the processor to determine factors reflecting the beat-to-beat variability in rate of successive heart beats, wherein the factors are lowest when the beat-to-beat variability is lowest and the factors increase non-linearly when the beat-to-beat variability grows, and wherein the factors comprise a first factor;
in response to the first factor reflecting beat-to-beat variability at a lower end of physiological values of a human heart, causing the processor to designate the variability reflected in the first factor as being substantially irrelevant to atrial fibrillation;
in response to the first factor reflecting beat-to-beat variability in a midrange of physiological values of a human heart, causing the processor to designate the variability reflected in the first factor as being positively indicative of atrial fibrillation;
in response to the first factor reflecting beat-to-beat variability in an upper range of physiological values of a human heart, causing the processor to designate the variability reflected in the first factor as being negatively indicative of atrial fibrillation;
causing the processor to determine a relevance of the variability to atrial fibrillation; and causing the processor to produce a signal indicating said relevance of the variability in heart rate to atrial fibrillation.
2. The method of claim 1, wherein designating variability comprises multiplying the first factor by a weighting factor.
3. The method of claim 1, wherein collecting information comprises collecting information describing a variability in R to R intervals over a series of beats.
4. The method of claim 3, wherein collecting information describing the variability comprises collecting information that is a function of a ratio of a first R to R interval and an immediately preceding R to R interval.
5. The method of claim 4, wherein the factors are factors DRR(n) as given by
6. The method of claim 5, wherein designating variability at the lower end of physiological values as being largely irrelevant comprises designating information related to factors DRR(n) less than about 0.02 as being largely irrelevant.
7. The method of claim 5, wherein designating variability at the midrange of physiological values as being indicative of atrial fibrillation comprises designating information related to factors DRR(n) greater than about 0.02 and less than about 0.15 as being indicative of atrial fibrillation.
8. The method of claim 5, wherein designating variability at the upper range of physiological values as being negatively indicative of atrial fibrillation comprises designating information related to factors DRR(n) greater than about 0.15 as being negatively indicative of atrial fibrillation.
9. The method of claim 1, wherein collecting information describing the variability comprises collecting the variability in heart rate over a series of between 20 and 200 of the recent R to R intervals.
10. The method of claim 1, wherein determining the relevance of the variability comprises determining the relevance of the variability to sustained atrial fibrillation.
11. The method of claim 1, wherein the series of R to R intervals is a continuous series of R to R intervals.
12. The method of any one of claims 1 to 11, wherein causing the processor to determine the relevance of the variability to atrial fibrillation comprises causing the processor to determine the relevance of the variability to atrial fibrillation using non-linear statistics.
13. The method of any one of claims 1 to 12, further comprising causing the processor to identify an atrial fibrillation event based on the determined relevance.
14. The method of claim 13, further comprising causing the processor to identify an end of the atrial fibrillation event based on the determined relevance.
15. The method of claim 13 or 14, further comprising causing the processor to transition into an event state associated with atrial fibrillation in response to identification of the atrial fibrillation event.
16. The method of claim 13, 14, or 15, further comprising causing the processor to transmit an indication of the atrial fibrillation event to a remote receiver from an ambulatory patient.
17. The method of any one of claims 1 to 16, wherein determining the relevance of the variability to atrial fibrillation comprises:
receiving information identifying a ventricular beat; and
18 assigning a preset value indicating that the variability is negatively indicative of atrial fibrillation.
18. The method of claim 17, further comprising causing the processor to identify a ventricular tachycardia event based at least in part on the information identifying the ventricular beat.
19. At least one computer-readable medium comprising codes stored thereon for directing a processor to:
collect information describing the variability in heart rate over a series of beats;
determine factors reflecting the beat-to-beat variability in rate of successive heart beats, wherein the factors are lowest when the beat-to-beat variability is lowest and the factors increase non-linearly when the beat-to-beat variability grows, and wherein the factors comprise a first factor;
in response to the first factor reflecting beat-to-beat variability at a lower end of physiological values of a human heart, designate the variability reflected in the first factor as being substantially irrelevant to atrial fibrillation;
in response to the first factor reflecting beat-to-beat variability in a midrange of physiological values of a human heart, designate the variability reflected in the first factor as being positively indicative of atrial fibrillation;
in response to the first factor reflecting beat-to-beat variability in an upper range of physiological values of a human heart, designate the variability reflected in the first factor as being negatively indicative of atrial fibrillation;
determine a relevance of the variability to atrial fibrillation; and produce a signal indicating said relevance of the variability in heart rate to atrial fibrillation.
20. The at least one computer-readable medium of claim 19, wherein the codes for directing the processor to designate variability comprise codes for directing the processor to multiply the first factor by a weighting factor.
21. The at least one computer-readable medium of claim 19, wherein the codes for directing the processor to collect information comprise codes for directing the processor to collect information describing a variability in R to R intervals over a series of beats.
22. The at least one computer-readable medium of claim 21, wherein the codes for directing the processor to collect information describing the variability comprise codes for directing the processor to collect information that is a function of a ratio of a first R to R interval and an immediately preceding R to R interval.
23. The at least one computer-readable medium of claim 22, wherein the factors are factors DRR(n) as given by
24. The at least one computer-readable medium of claim 23, wherein the codes for directing the processor to designate variability at the lower end of physiological values as being largely irrelevant comprise codes for directing the processor to designate information related to factors DRR(n) less than about 0.02 as being largely irrelevant.
25. The at least one computer-readable medium of claim 23 or 24, wherein the codes for directing the processor to designate variability at the midrange of physiological values as being indicative of atrial fibrillation comprise codes for directing the processor to designate information related to factors DRR(n) greater than about 0.02 and less than about 0.15 as being indicative of atrial fibrillation.
26. The at least one computer-readable medium of claim 23, 24, or 25, wherein the codes for directing the processor to designate variability at the upper range of physiological values as being negatively indicative of atrial fibrillation comprise codes for directing the processor to designate information related to factors DRR(n) greater than about 0.15 as being negatively indicative of atrial fibrillation.
27. The at least one computer-readable medium of claim 19, wherein the codes for directing the processor to collect information describing the variability comprise codes for directing the processor to collect the variability in heart rate over a series of between 20 and 200 of the recent R to R intervals.
28. The at least one computer-readable medium of claim 19, wherein the codes for directing the processor to determine the relevance of the variability comprise codes for directing the processor to determine the relevance of the variability to sustained atrial fibrillation.
29. The at least one computer-readable medium of claim 19, wherein the series of R to R
intervals is a continuous series of R to R intervals.
30. The at least one computer-readable medium of any one of claims 19 to 29, wherein the codes for directing the processor to determine the relevance of the variability to atrial fibrillation comprise codes for directing the processor to determine the relevance of the variability to atrial fibrillation using non-linear statistics.
31. The at least one computer-readable medium of any one of claims 19 to 30, further comprising codes stored thereon for directing the processor to identify an atrial fibrillation event based on the determined relevance.
32. The at least one computer-readable medium of claim 31, further comprising codes stored thereon for directing the processor to identify an end of the atrial fibrillation event based on the determined relevance.
33. The at least one computer-readable medium of claim 31 or 32, further comprising codes stored thereon for directing the processor to transition into an event state associated with atrial fibrillation in response to identification of the atrial fibrillation event.
34. The at least one computer-readable medium of claim 31, 32, or 33, further comprising codes stored thereon for directing the processor to cause an indication of the atrial fibrillation event to be transmitted to a remote receiver from an ambulatory patient.
35. The at least one computer-readable medium of any one of claims 19 to 34, wherein the codes for directing the processor to determine the relevance of the variability to atrial fibrillation comprise:
codes for directing the processor to receive information identifying a ventricular beat; and codes for directing the processor to assign a preset value indicating that the variability is negatively indicative of atrial fibrillation.
36. The at least one computer-readable medium of claim 35, further comprising codes stored thereon for directing the processor to identify a ventricular tachycardia event based at least in part on the information identifying the ventricular beat.
37. An apparatus for producing an indication of relevance of variability in heart rate to atrial fibrillation, the apparatus comprising:
the at least one computer-readable medium of any one of claims 19 to 36; and the processor.
38. An apparatus for producing an indication of relevance of variability in heart rate to atrial fibrillation, the apparatus comprising:
a means for collecting information describing the variability in heart rate over a series of beats;

a means for determining factors reflecting the beat-to-beat variability in rate of successive heart beats, wherein the factors are lowest when the beat-to-beat variability is lowest and the factors increase non-linearly when the beat-to-beat variability grows, and wherein the factors comprise a first factor;
a means for designating the variability reflected in the first factor as being substantially irrelevant to atrial fibrillation if the first factor reflects beat-to-beat variability at a lower end of physiological values of a human heart, for designating the variability reflected in the first factor as being positively indicative of atrial fibrillation if the first factor reflects beat-to-beat variability in a midrange of physiological values of a human heart, and for designating the variability reflected in the first factor as being negatively indicative of atrial fibrillation if the first factor reflects beat-to-beat variability in an upper range of physiological values of a human heart;
a means for determining a relevance of the variability to atrial fibrillation;
and a means for producing a signal indicating said relevance of the variability in heart rate to atrial fibrillation.
39. The apparatus of claim 38, wherein the means for designating variability comprises a means for multiplying the first factor by a weighting factor.
40. The apparatus of claim 38, wherein the means for collecting information is configured to collect information describing a variability in R to R intervals over a series of beats.
41. The apparatus of claim 40, wherein the means for collecting information is configured to collect information that is a function of a ratio of a first R
to R interval and an immediately preceding R to R interval.
42. The apparatus of claim 41, wherein the factors are factors DRR(n) as given by
43. The apparatus of claim 42, wherein the means for designating variability is configured to designate variability at the lower end of physiological values as being largely irrelevant if information related to factors DRR(n) is less than about 0.02.
44. The apparatus of claim 42 or 43, wherein the means for designating variability is configured to designate variability at the midrange of physiological values as being indicative of atrial fibrillation if information related to factors DRR(n) is greater than about 0.02 and less than about 0.15.
45. The apparatus of claim 42, 43, or 44, wherein the means for designating variability is configured to designate variability at the upper range of physiological values as being negatively indicative of atrial fibrillation if information related to factors DRR(n) is greater than about 0.15.
46. The apparatus of claim 38, wherein the means for collecting information comprises a means for collecting the variability in heart rate over a series of between 20 and 200 of the recent R to R intervals.
47. The apparatus of claim 38, wherein the means for determining the relevance of the variability comprises a means for determining the relevance of the variability to sustained atrial fibrillation.
48. The apparatus of claim 38, wherein the series of R to R intervals is a continuous series of R to R intervals.
49. The apparatus of any one of claims 38 to 48, wherein the means for determining the relevance of the variability to atrial fibrillation is configured to determine the relevance of the variability to atrial fibrillation using non-linear statistics.
50. The apparatus of any one of claims 38 to 49, further comprising a means for identifying an atrial fibrillation event based on the determined relevance.
51. The apparatus of claim 50, further comprising a means for identifying an end of the atrial fibrillation event based on the determined relevance.
52. The apparatus of claim 50 or 51, further comprising a means for transitioning into an event state associated with atrial fibrillation in response to identification of the atrial fibrillation event.
53. The apparatus of claim 50, 51, or 52, further comprising a means for transmitting an indication of the atrial fibrillation event to a remote receiver from an ambulatory patient.
54. The apparatus of any one of claims 20 to 53, wherein the means for determining the relevance of the variability to atrial fibrillation comprises:
a means for receiving information identifying a ventricular beat; and a means for assigning a preset value indicating that the variability is negatively indicative of atrial fibrillation.
55. The apparatus of claim 54, further comprising a means for identifying a ventricular tachycardia event based at least in part on the information identifying the ventricular beat.
CA2550573A 2004-01-21 2005-01-21 Cardiac monitoring Expired - Fee Related CA2550573C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/762,887 2004-01-21
US10/762,887 US7194300B2 (en) 2004-01-21 2004-01-21 Cardiac monitoring
PCT/US2005/001849 WO2005072237A2 (en) 2004-01-21 2005-01-21 Cardiac monitoring

Publications (2)

Publication Number Publication Date
CA2550573A1 CA2550573A1 (en) 2005-08-11
CA2550573C true CA2550573C (en) 2013-07-30

Family

ID=34750385

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2550573A Expired - Fee Related CA2550573C (en) 2004-01-21 2005-01-21 Cardiac monitoring

Country Status (8)

Country Link
US (2) US7194300B2 (en)
EP (1) EP1706031B1 (en)
JP (1) JP4602354B2 (en)
CN (2) CN102670189B (en)
AU (1) AU2005208762B2 (en)
CA (1) CA2550573C (en)
ES (1) ES2638437T3 (en)
WO (1) WO2005072237A2 (en)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8734339B2 (en) * 1996-12-16 2014-05-27 Ip Holdings, Inc. Electronic skin patch for real time monitoring of cardiac activity and personal health management
US20050131465A1 (en) 2000-02-04 2005-06-16 Freeman Gary A. Integrated resuscitation
WO2005096922A1 (en) * 2004-03-31 2005-10-20 Masimo Corporation Physiological assessment system
US7596405B2 (en) * 2005-03-07 2009-09-29 United Therapeutics Corporation Atrial fibrillation detection
DE102005047320A1 (en) * 2005-09-30 2007-04-05 Biotronik Crm Patent Ag Detector for atrial flicker and flutter
EP1952291A1 (en) * 2005-10-14 2008-08-06 Medicalgorithmics Sp. Z.O.O. Method, device and system for lead-limited electrocardiography (ecg) signal analysis
US8818496B2 (en) 2005-10-14 2014-08-26 Medicalgorithmics Ltd. Systems for safe and remote outpatient ECG monitoring
US7978062B2 (en) 2007-08-31 2011-07-12 Cardiac Pacemakers, Inc. Medical data transport over wireless life critical network
US9848058B2 (en) 2007-08-31 2017-12-19 Cardiac Pacemakers, Inc. Medical data transport over wireless life critical network employing dynamic communication link mapping
US7970463B2 (en) * 2007-12-20 2011-06-28 Cardiac Pacemakers, Inc. Anti-tachyarrhythmia system with unified atrial tachyarrhythmia rate threshold
US8121675B2 (en) * 2008-04-25 2012-02-21 Pacesetter, Inc. Device and method for detecting atrial fibrillation
US8233973B2 (en) 2008-05-02 2012-07-31 Spacelabs Healthcare, Llc Methods for detection of cardiac arrhythmias
US8812841B2 (en) * 2009-03-04 2014-08-19 Cardiac Pacemakers, Inc. Communications hub for use in life critical network
US8319631B2 (en) 2009-03-04 2012-11-27 Cardiac Pacemakers, Inc. Modular patient portable communicator for use in life critical network
US9655518B2 (en) 2009-03-27 2017-05-23 Braemar Manufacturing, Llc Ambulatory and centralized processing of a physiological signal
US8301236B2 (en) * 2009-05-22 2012-10-30 Biomedical Systems Corporation System and method for high resolution wireless full disclosure ECG episode monitoring and analysis
EP2490587A1 (en) 2009-10-20 2012-08-29 Widemed Ltd. Method and system for detecting cardiac arrhythmia
US20110152957A1 (en) * 2009-12-21 2011-06-23 Cem Shaquer Chaos-based detection of atrial fibrillation using an implantable medical device
DK2568878T3 (en) 2010-05-12 2018-10-29 Irhythm Tech Inc Interior features and design elements for long-term adhesion
US9585584B2 (en) 2010-05-21 2017-03-07 Medicomp, Inc. Physiological signal monitor with retractable wires
CA2973994C (en) 2010-05-21 2019-05-21 Medicomp, Inc. Method of determining optimum electrode vector length between two sensing connectors of a cardiac monitor
US8798732B2 (en) 2010-08-05 2014-08-05 Lev-El Diagnostics of Heart Diseases Ltd. Apparatus, system and method of determining a heart rate variability value
US8437851B2 (en) * 2010-10-26 2013-05-07 Medtronic, Inc. Diagnosis and therapy of bigeminy and frequent premature contractions
CN102028460B (en) * 2011-01-04 2014-01-08 复旦大学 Ventricular fibrillation signal sequence automatic-detection system
US9307914B2 (en) 2011-04-15 2016-04-12 Infobionic, Inc Remote data monitoring and collection system with multi-tiered analysis
US8744559B2 (en) * 2011-08-11 2014-06-03 Richard P. Houben Methods, systems and devices for detecting atrial fibrillation
JP5951211B2 (en) * 2011-10-04 2016-07-13 オリンパス株式会社 Focus control device and endoscope device
CN102429656A (en) * 2011-10-21 2012-05-02 上海理工大学 Ultra-small ventricular fibrillation detector
US8838224B2 (en) * 2012-03-30 2014-09-16 General Electric Company Method, apparatus and computer program product for predicting ventricular tachyarrhythmias
US10758141B2 (en) 2012-04-23 2020-09-01 Biosense Webster (Israel) Ltd. Cardiac activation time detection
US9833157B2 (en) 2012-04-23 2017-12-05 Biosense Webster (Israel) Ltd. Cardiac activation time detection
US10244949B2 (en) 2012-10-07 2019-04-02 Rhythm Diagnostic Systems, Inc. Health monitoring systems and methods
USD850626S1 (en) 2013-03-15 2019-06-04 Rhythm Diagnostic Systems, Inc. Health monitoring apparatuses
US10413251B2 (en) 2012-10-07 2019-09-17 Rhythm Diagnostic Systems, Inc. Wearable cardiac monitor
US10610159B2 (en) 2012-10-07 2020-04-07 Rhythm Diagnostic Systems, Inc. Health monitoring systems and methods
KR20140063100A (en) * 2012-11-16 2014-05-27 삼성전자주식회사 Apparatus and methods for remote cardiac disease management
AU2014209376B2 (en) 2013-01-24 2017-03-16 Irhythm Technologies, Inc. Physiological monitoring device
JP2014171589A (en) * 2013-03-07 2014-09-22 Seiko Epson Corp Atrial fibrillation analyzation equipment and program
USD921204S1 (en) 2013-03-15 2021-06-01 Rds Health monitoring apparatus
EP2983593B1 (en) 2013-04-08 2021-11-10 Irhythm Technologies, Inc. Skin abrader
JP6434129B2 (en) * 2014-08-14 2018-12-05 カーディアック ペースメイカーズ, インコーポレイテッド Detection of atrial fibrillation using heart rate variability
WO2016070128A1 (en) 2014-10-31 2016-05-06 Irhythm Technologies, Inc. Wireless physiological monitoring device and systems
EP3204881B1 (en) 2014-11-14 2021-05-26 Zoll Medical Corporation Medical premonitory event estimation
US11331034B2 (en) 2015-10-27 2022-05-17 Cardiologs Technologies Sas Automatic method to delineate or categorize an electrocardiogram
US10827938B2 (en) 2018-03-30 2020-11-10 Cardiologs Technologies Sas Systems and methods for digitizing electrocardiograms
PT3367897T (en) 2015-10-27 2021-05-25 Cardiologs Tech An automatic method to delineate or categorize an electrocardiogram
US10426364B2 (en) 2015-10-27 2019-10-01 Cardiologs Technologies Sas Automatic method to delineate or categorize an electrocardiogram
US11672464B2 (en) 2015-10-27 2023-06-13 Cardiologs Technologies Sas Electrocardiogram processing system for delineation and classification
EP3367884B1 (en) * 2015-10-29 2020-07-22 Cardiac Pacemakers, Inc. Prediction of worsening of heart failure
WO2017140663A1 (en) * 2016-02-15 2017-08-24 Koninklijke Philips N.V. Device and method for extracting heart rate information
USD794807S1 (en) 2016-04-29 2017-08-15 Infobionic, Inc. Health monitoring device with a display
USD794806S1 (en) 2016-04-29 2017-08-15 Infobionic, Inc. Health monitoring device
USD794805S1 (en) 2016-04-29 2017-08-15 Infobionic, Inc. Health monitoring device with a button
US9968274B2 (en) 2016-04-29 2018-05-15 Infobionic, Inc. Systems and methods for processing ECG data
FR3053238A1 (en) 2016-06-30 2018-01-05 Universite D'aix-Marseille METHOD FOR DETECTING AT LEAST ONE HEART RHYTHM DISORDER
FR3053237A1 (en) 2016-06-30 2018-01-05 Universite D'aix-Marseille DEVICE FOR DETECTING AT LEAST ONE HEART RHYTHM DISORDER
US11009870B2 (en) 2017-06-06 2021-05-18 Zoll Medical Corporation Vehicle compatible ambulatory defibrillator
US10660529B2 (en) 2017-07-07 2020-05-26 National Cardiac, Inc. Cardiac monitor with perturbation evaluation
US10709343B2 (en) 2017-07-31 2020-07-14 National Cardiac, Inc. Computer-based systems and methods for monitoring the heart muscle of a patient with contextual oversight
JP2020531225A (en) 2017-08-25 2020-11-05 カーディオログス テクノロジーズ エスアーエス User interface for electrocardiogram analysis
US11568397B2 (en) 2019-04-24 2023-01-31 Cerner Innovation, Inc. Providing a financial/clinical data interchange
US11253162B2 (en) * 2019-06-11 2022-02-22 GE Precision Healthcare LLC Method and system for heart rate estimation
US11730418B2 (en) 2019-08-22 2023-08-22 West Affum Holdings Dac Cardiac monitoring system with supraventricular tachycardia (SVT) classifications
US11771360B2 (en) 2019-08-22 2023-10-03 West Affum Holdings Dac Cardiac monitoring system with normally conducted QRS complex identification
CN110477904B (en) * 2019-08-26 2022-05-31 北京蓬阳丰业科技有限公司 House flapping signal detection method and device
WO2021041961A1 (en) 2019-08-28 2021-03-04 Rhythm Diagnostic Systems, Inc. Vital signs or health monitoring systems and methods
US20210275110A1 (en) 2019-12-30 2021-09-09 RubyElf, LLC Systems For Synchronizing Different Devices To A Cardiac Cycle And For Generating Pulse Waveforms From Synchronized ECG and PPG Systems
US11461361B2 (en) 2019-12-31 2022-10-04 Cerner Innovation, Inc. Rapid hyperledger onboarding platform
KR102563372B1 (en) 2020-02-12 2023-08-03 아이리듬 테크놀로지스, 아이엔씨 Method for Inferring Patient Physiological Characteristics Using Non-Invasive Cardiac Monitors and Recorded Cardiac Data
CN115884808A (en) * 2020-06-08 2023-03-31 株式会社钟化 Electrical device for defibrillation and method for generating defibrillation signal
CN115884809A (en) * 2020-06-08 2023-03-31 株式会社钟化 Electrical device for defibrillation and method for generating defibrillation signal
US11523766B2 (en) 2020-06-25 2022-12-13 Spacelabs Healthcare L.L.C. Systems and methods of analyzing and displaying ambulatory ECG data
KR20230047456A (en) 2020-08-06 2023-04-07 아이리듬 테크놀로지스, 아이엔씨 Electrical Components for Physiological Monitoring Devices
CN116322497A (en) 2020-08-06 2023-06-23 意锐瑟科技公司 Viscous physiological monitoring device
US11678831B2 (en) 2020-08-10 2023-06-20 Cardiologs Technologies Sas Electrocardiogram processing system for detecting and/or predicting cardiac events

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US664893A (en) * 1900-03-31 1901-01-01 Peter C Peterson Spraying-nozzle.
US4621617A (en) * 1981-06-29 1986-11-11 Sharma Devendra N Electro-magnetically controlled artificial heart device for compressing cardiac muscle
US4630204A (en) * 1984-02-21 1986-12-16 Mortara Instrument Inc. High resolution ECG waveform processor
US4622979A (en) * 1984-03-02 1986-11-18 Cardiac Monitoring, Inc. User-worn apparatus for monitoring and recording electrocardiographic data and method of operation
US4920489A (en) * 1987-08-14 1990-04-24 Cardiodata Inc. Apparatus and method for solid state storage of episodic signals
US4951681A (en) * 1988-11-14 1990-08-28 Mortara Instrument Electrocardiographic recording method and apparatus
US4938228A (en) * 1989-02-15 1990-07-03 Righter William H Wrist worn heart rate monitor
US4977899A (en) * 1989-03-10 1990-12-18 Instromedix, Inc. Heart data monitoring method and apparatus
US4958641A (en) * 1989-03-10 1990-09-25 Instromedix, Inc. Heart data monitoring method and apparatus
USD326716S (en) * 1990-02-22 1992-06-02 Mortara Instrument Medical cable
FR2671278B1 (en) * 1990-12-13 1998-01-16 Odam METHOD FOR RECOGNITION OF A VENTRICULAR CARDIAC CONDITION FOR AUTOMATIC DEFIBRILLATION AND MONITOR-DEFIBRILLATOR FOR IMPLEMENTING IT.
US5421342A (en) * 1991-01-18 1995-06-06 Mortara Instrument, Inc. Filter apparatus and method for reducing signal noise using multiple signals obtained from a single source
US5197479A (en) * 1991-05-13 1993-03-30 Mortara Instrument Automatic electrode channel impedance measurement system for egg monitor
US5226425A (en) * 1991-09-10 1993-07-13 Ralin, Inc. Portable ECG monitor/recorder
US5191891A (en) * 1991-09-10 1993-03-09 Ralin, Inc. Portable ECG monitor/recorder
ATE197761T1 (en) 1992-04-03 2000-12-15 Micromedical Ind Ltd ARRANGEMENT FOR MONITORING PHYSIOLOGICAL PARAMETERS
US5966692A (en) 1992-05-12 1999-10-12 Telemed Technologies International Corporation Method and system for monitoring the heart of a patient
US5522396A (en) * 1992-05-12 1996-06-04 Cardiac Telecom Corporation Method and system for monitoring the heart of a patient
US5581369A (en) * 1992-09-25 1996-12-03 Ralin, Inc. Apparatus and method for communicating electrocardiographic data to a facsimile machine
US5456261A (en) * 1993-12-16 1995-10-10 Marquette Electronics, Inc. Cardiac monitoring and diagnostic system
US5546950A (en) * 1994-07-06 1996-08-20 Mortara Instrument, Inc. Electrocardiograpic patient lead cable apparatus
US5704351A (en) * 1995-02-28 1998-01-06 Mortara Instrument, Inc. Multiple channel biomedical digital telemetry transmitter
USD377983S (en) * 1995-09-13 1997-02-11 Mohamed Sabri Cardiac monitor
US5678562A (en) 1995-11-09 1997-10-21 Burdick, Inc. Ambulatory physiological monitor with removable disk cartridge and wireless modem
US5730143A (en) * 1996-05-03 1998-03-24 Ralin Medical, Inc. Electrocardiographic monitoring and recording device
SE506300C2 (en) * 1996-06-18 1997-12-01 Bertil Olsson Apparatus for frequency analysis of atrial fibrillation
EP0944414B1 (en) * 1996-07-11 2005-11-09 Medtronic, Inc. Minimally invasive implantable device for monitoring physiologic events
US6102856A (en) 1997-02-12 2000-08-15 Groff; Clarence P Wearable vital sign monitoring system
JPH10234688A (en) * 1997-02-24 1998-09-08 Shigunarisu:Kk Portable electrocardiograph monitoring device
US6226599B1 (en) * 1997-03-05 2001-05-01 Fujitsu Limted Electromagnetic wave analyzer apparatus
US5959529A (en) 1997-03-07 1999-09-28 Kail, Iv; Karl A. Reprogrammable remote sensor monitoring system
US5840038A (en) * 1997-05-29 1998-11-24 Marquette Medical Systems, Inc. Method and apparatus for signal averaging and analyzing high resolution P wave signals from an electrocardiogram
US5931791A (en) * 1997-11-05 1999-08-03 Instromedix, Inc. Medical patient vital signs-monitoring apparatus
USD414870S (en) * 1998-01-02 1999-10-05 Instromedix, Inc. Vital signs monitor
US6366871B1 (en) * 1999-03-03 2002-04-02 Card Guard Scientific Survival Ltd. Personal ambulatory cellular health monitor for mobile patient
US7299159B2 (en) * 1998-03-03 2007-11-20 Reuven Nanikashvili Health monitor system and method for health monitoring
US7222054B2 (en) * 1998-03-03 2007-05-22 Card Guard Scientific Survival Ltd. Personal ambulatory wireless health monitor
US7542878B2 (en) * 1998-03-03 2009-06-02 Card Guard Scientific Survival Ltd. Personal health monitor and a method for health monitoring
US20020029391A1 (en) * 1998-04-15 2002-03-07 Claude Geoffrey Davis Epitope-driven human antibody production and gene expression profiling
US5967995A (en) * 1998-04-28 1999-10-19 University Of Pittsburgh Of The Commonwealth System Of Higher Education System for prediction of life-threatening cardiac arrhythmias
JP2000166889A (en) * 1998-12-11 2000-06-20 Inst Of Physical & Chemical Res Heart rate fluctuation estimation method and device thereof
US6287252B1 (en) 1999-06-30 2001-09-11 Monitrak Patient monitor
US6289243B1 (en) * 1999-12-01 2001-09-11 Cardiac Science, Inc. Automatic external cardioverter/defibrillator with tachyarrhythmia detector using a modulation (amplitude and frequency) domain function
US20020023134A1 (en) * 2000-04-03 2002-02-21 Roskowski Steven G. Method and computer program product for establishing real-time communications between networked computers
US6496731B1 (en) * 2000-04-14 2002-12-17 Cardiac Pacemakers, Inc. Highly specific technique for discriminating atrial fibrillation from atrial flutter
DE60102836T2 (en) * 2000-11-28 2005-04-21 Medtronic Inc DEVICE FOR DETECTING A VORHOFFIBRILLATION BY MEANS OF HEART CHAMBER DETECTION
US6490479B2 (en) * 2000-12-28 2002-12-03 Ge Medical Systems Information Technologies, Inc. Atrial fibrillation detection method and apparatus
US6569095B2 (en) 2001-04-23 2003-05-27 Cardionet, Inc. Adaptive selection of a warning limit in patient monitoring
US6801137B2 (en) 2001-04-23 2004-10-05 Cardionet, Inc. Bidirectional communication between a sensor unit and a monitor unit in patient monitoring
US6664893B1 (en) 2001-04-23 2003-12-16 Cardionet, Inc. Method for controlling access to medical monitoring device service
US6665385B2 (en) 2001-04-23 2003-12-16 Cardionet, Inc. Medical monitoring system having multipath communications capability
US6694177B2 (en) 2001-04-23 2004-02-17 Cardionet, Inc. Control of data transmission between a remote monitoring unit and a central unit
KR20040007504A (en) 2001-04-23 2004-01-24 카디오네트, 인코포레이티드 Correlation of sensor signals with subjective information in patient monitoring
US7187965B2 (en) * 2001-05-29 2007-03-06 Bischoff Edward T Cardiac rhythm monitoring device
CN1180746C (en) * 2001-06-26 2004-12-22 陈士良 Cardioelectric spectrometer
US20030028442A1 (en) * 2001-08-06 2003-02-06 Craig Wagstaff Method of supplying heart screening services directly to a customer
US6697655B2 (en) * 2001-10-05 2004-02-24 Mortara Instrument, Inc. Low power pulse oximeter
US6564077B2 (en) * 2001-10-10 2003-05-13 Mortara Instrument, Inc. Method and apparatus for pulse oximetry
US6980851B2 (en) * 2001-11-15 2005-12-27 Cardiac Pacemakers, Inc. Method and apparatus for determining changes in heart failure status
US6957107B2 (en) 2002-03-13 2005-10-18 Cardionet, Inc. Method and apparatus for monitoring and communicating with an implanted medical device
US7146206B2 (en) * 2002-03-20 2006-12-05 Medtronic, Inc. Detection of cardiac arrhythmia using mathematical representation of standard ΔRR probability density histograms
US7283863B2 (en) * 2002-04-29 2007-10-16 Medtronic, Inc. Method and apparatus for identifying cardiac and non-cardiac oversensing using intracardiac electrograms
US6871089B2 (en) * 2002-06-05 2005-03-22 Card Guard Technologies, Inc. Portable ECG monitor and method for atrial fibrillation detection
US7311665B2 (en) * 2003-05-19 2007-12-25 Alcohol Monitoring Systems, Inc. Bio-information sensor monitoring system and method
CA2538710A1 (en) * 2003-09-12 2005-03-31 Bodymedia, Inc. Method and apparatus for measuring heart related parameters
US7512438B2 (en) * 2003-11-26 2009-03-31 Angel Medical Systems, Inc. Implantable system for monitoring the condition of the heart
US7693574B2 (en) * 2005-08-31 2010-04-06 Cardiac Pacemakers, Inc. System and method for discriminating high frequency electromagnetic interference from cardiac events
US20070100213A1 (en) 2005-10-27 2007-05-03 Dossas Vasilios D Emergency medical diagnosis and communications device

Also Published As

Publication number Publication date
US20050159667A1 (en) 2005-07-21
EP1706031B1 (en) 2017-06-21
CN1909831A (en) 2007-02-07
JP2007516815A (en) 2007-06-28
CN1909831B (en) 2012-07-04
US7941207B2 (en) 2011-05-10
CN102670189A (en) 2012-09-19
US7194300B2 (en) 2007-03-20
WO2005072237A3 (en) 2006-04-13
ES2638437T3 (en) 2017-10-20
EP1706031A2 (en) 2006-10-04
WO2005072237A2 (en) 2005-08-11
EP1706031A4 (en) 2010-04-07
CA2550573A1 (en) 2005-08-11
AU2005208762A1 (en) 2005-08-11
AU2005208762B2 (en) 2008-07-31
US20070129642A1 (en) 2007-06-07
CN102670189B (en) 2016-01-20
JP4602354B2 (en) 2010-12-22

Similar Documents

Publication Publication Date Title
CA2550573C (en) Cardiac monitoring
US7623911B2 (en) Method and apparatus for detection of tachyarrhythmia using cycle lengths
US7537569B2 (en) Method and apparatus for detection of tachyarrhythmia using cycle lengths
CN106659900B (en) Implantable medical device with autocorrelation device and with analysis device for estimating heart rate
CN109843166B (en) System for arrhythmia detection
US7289844B2 (en) System process for analyzing the medical condition of a user
US9031645B2 (en) Methods, systems and devices for detecting atrial fibrillation
US5682901A (en) Method and apparatus for measuring autonomic activity of a patient
JP5090924B2 (en) System for detecting and monitoring T-wave alternation
US20120238891A1 (en) Methods for ectopy rejection for atrial fibrillation detection based on ventricular cycle lengths
JP2013521867A (en) Time-frequency noise detection of intracardiac electrogram
US11918815B2 (en) Cardiac signal T-wave detection
Setiawidayat et al. Determining the ECG 1 cycle wave using Discrete data

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20200121